Daily Guru Alerts
- Dylan Jovine
- Thursday, September 21, 2023
I’ve been touting Iovance (SYM: IOVA) for so long, I may have to fall on my sword Japanese-style if it doesn’t work out.
- Dylan Jovine
- Monday, July 10, 2023
Iovance (SYM: IOVA) jumped 20% today after announcing news that its lung cancer candidate LN-145 could be acceptable for a potential accelerated approval.
- Dylan Jovine
- Thursday, June 1, 2023
We have a strong group of stocks, so I want to take today to highlight some of the best opportunities I haven’t talked about recently (and update others).
- Dylan Jovine
- Thursday, May 25, 2023
A lot of newer members have written in to ask about Iovance Biotherapeutics (SYM: IOVA).
- Dylan Jovine
- Thursday, April 27, 2023
Two things I want to discuss this week…
- Dylan Jovine
- Thursday, January 26, 2023
We haven’t talked about Iovance Bio (SYM: IOVA) in a while. I figured I’d use this issue to update you on it, since there were slim pickins’ out there this week anyway.
- Dylan Jovine
- Tuesday, August 16, 2022
Every year, millions of lives are irrevocably changed as they grapple with the devastating impacts of a cancer diagnosis.
- Dylan Jovine
- Thursday, June 2, 2022
I like the team that runs Diamondback Energy.
- Dylan Jovine
- Thursday, September 21, 2023
I’ve been touting Iovance (SYM: IOVA) for so long, I may have to fall on my sword Japanese-style if it doesn’t work out.
- Dylan Jovine
- Monday, July 10, 2023
Iovance (SYM: IOVA) jumped 20% today after announcing news that its lung cancer candidate LN-145 could be acceptable for a potential accelerated approval.
- Dylan Jovine
- Thursday, June 1, 2023
We have a strong group of stocks, so I want to take today to highlight some of the best opportunities I haven’t talked about recently (and update others).
- Dylan Jovine
- Thursday, May 25, 2023
A lot of newer members have written in to ask about Iovance Biotherapeutics (SYM: IOVA).
- Dylan Jovine
- Thursday, April 27, 2023
Two things I want to discuss this week…
- Dylan Jovine
- Thursday, January 26, 2023
We haven’t talked about Iovance Bio (SYM: IOVA) in a while. I figured I’d use this issue to update you on it, since there were slim pickins’ out there this week anyway.
- Dylan Jovine
- Tuesday, August 16, 2022
Every year, millions of lives are irrevocably changed as they grapple with the devastating impacts of a cancer diagnosis.
- Dylan Jovine
- Thursday, June 2, 2022
I like the team that runs Diamondback Energy.
deal of the month
Categories
A Warning for US Investors #shorts
Protecting Your Portfolio from the Rise of China #shorts
US Military LOSES in Simulated War Games Against China #shorts
Recent posts
Tags
Connect with Us
Get FREE Daily Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
